bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia

Oncogene Res. 1988;3(4):387-99.

Abstract

In chronic myeloid leukemia (CML), a chromosome translocation has fused the bcr gene to the c-abl oncogene, such that a chimeric bcr-abl polypeptide can be made. To explore the biological properties of bcr-abl and compare them with those of the Abelson virus (AMuLV) transforming gene (gag-v-abl), we have used either a synthetic bcr-v-abl gene that mimics the translocation product or, in some experiments, a bcr-c-abl cDNA. A new retroviral vector was used to introduce the genes into the factor-dependent myeloid line FDC-P1. Both bcr-abl and v-abl efficiently rendered the myeloid cells factor independent and tumorigenic. Their fully autonomous growth may be due to the myeloid growth factor interleukin-3 (IL-3) made in small amounts by the infected cells. Hence autocrine factor production may feature in CML development and Abelson virus transformation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Division
  • Cell Line
  • Cell Transformation, Neoplastic / genetics*
  • Fusion Proteins, bcr-abl
  • Gene Expression Regulation
  • Genetic Engineering
  • Growth Substances / biosynthesis*
  • Interleukin-3 / biosynthesis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / physiopathology
  • Mice
  • Neoplasm Proteins / physiology*
  • Neoplasms, Experimental / genetics*
  • Neoplasms, Experimental / pathology
  • Transfection

Substances

  • Growth Substances
  • Interleukin-3
  • Neoplasm Proteins
  • Fusion Proteins, bcr-abl